Bridger Management 13F, Q2 2024
Roberto Mignone · quarter ending 30 June 2024 · filed 14 August 2024 · SEC CIK 1166309
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q2 2024
The 25 largest of 28 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2024 filing.
| Company | Ticker | Value | % of book | vs Q1 2024 |
|---|---|---|---|---|
| ELI LILLY & CO | LLY | $22.37M | 11.5% | -12% shares |
| UBER TECHNOLOGIES INC | UBER | $21.91M | 11.3% | unchanged |
| VERTEX PHARMACEUTICALS INC | VRTX | $19.24M | 9.9% | unchanged |
| MORGAN STANLEY | MS | $18.24M | 9.4% | unchanged |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $15.94M | 8.2% | -35% shares |
| PFIZER INC | PFE | $9.81M | 5.0% | unchanged |
| TAIWAN SEMICONDUCTOR MFG LTD | TSM | $9.01M | 4.6% | unchanged |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $9.00M | 4.6% | -30% shares |
| BATH & BODY WORKS INC | BBWI | $8.67M | 4.5% | -14% shares |
| BAUSCH PLUS LOMB CORP | BLCO | $7.35M | 3.8% | new |
| MELCO RESORTS AND ENTMNT LTD | MLCO | $7.34M | 3.8% | +14% shares |
| CAESARS ENTERTAINMENT INC NE | CZR | $5.87M | 3.0% | unchanged |
| XENON PHARMACEUTICALS INC | XENE | $5.72M | 3.0% | unchanged |
| GERON CORP | GERN | $5.67M | 2.9% | unchanged |
| SPRINGWORKS THERAPEUTICS INC | $5.44M | 2.8% | unchanged | |
| DEXCOM INC | DXCM | $3.28M | 1.7% | unchanged |
| CATALYST PHARMACEUTICALS INC | CPRX | $2.86M | 1.5% | unchanged |
| ALPHABET INC | GOOGL | $2.53M | 1.3% | unchanged |
| QUANTERIX CORP | QTRX | $2.05M | 1.1% | unchanged |
| HILLEVAX INC | $2.03M | 1.0% | +30% shares | |
| MICROSOFT CORP | MSFT | $1.89M | 1.0% | unchanged |
| TERNS PHARMACEUTICALS INC | 430 | $1.68M | 0.9% | unchanged |
| UNIQURE NV | $1.62M | 0.8% | unchanged | |
| OSCAR HEALTH INC | OSCR | $1.51M | 0.8% | new |
| AMAZON COM INC | AMZN | $1.40M | 0.7% | unchanged |
What changed since Q1 2024
Against the Q1 2024 filing, Bridger Management opened 2 new positions, added to 2, trimmed 4, left 20 unchanged and exited 5. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001166309-24-000016, filed by BRIDGER MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.